Symbiobe

Symbiobe is a biotech company in Kyoto, Japan, founded in 2021. It has 1 recorded funding round, most recently a Seed in December 2023.

Turning air into resources.

Headquarters
Kyoto
Founded
2021
Last Round
SeedDec 2023
Rounds
1

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

Symbiobe is a Kyoto-based biotechnology company, spun out of Kyoto University, that develops carbon and nitrogen fixation technology using marine photosynthetic purple bacteria. Founded in January 2021 by Professor Keiji Numata of Kyoto University's Graduate School of Engineering, the company's platform converts atmospheric and oceanic resources into sustainable materials including organic fertilizers, aquaculture feeds, and biodegradable plastics. Symbiobe's mission is to build a symbiotic relationship between humanity and the planet by commercializing biology-based resource recycling at industrial scale.

Summary

Its most recent funding was a Seed round in Dec 2023. Investors include Global Brain.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
SeedSeed RoundDec 2023

Investors

Similar Companies

Sempra Infrastructure Partners

Sempra Infrastructure develops, builds, operates, and invests in infrastructure serving customers...

San Diego, United States1001–5000Climate Tech
Corporate RoundTotal funding$12.1BSep 2025
Crusoe

AI infrastructure company building renewable-powered data centers and cloud compute optimized for...

Denver, United States201–500Artificial Intelligence, Clean Energy
Series FTotal funding$9.4BSep 2026
CruiseClosed

Self-driving cars.

San Francisco, United States1001–5000Artificial Intelligence, Autonomous Vehicles
Growth EquityTotal funding$6.9BJan 2021
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Stegra

Green steel company using hydrogen and renewable electricity to decarbonize steel production. For...

Stockholm, Sweden201–500Clean Tech, Climate Tech
Venture RoundTotal funding$4.6BJun 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Symbiobe on Indexed.vc
<a href="https://indexed.vc/companies/symbiobe"><img src="https://indexed.vc/api/badge/company/symbiobe" alt="Symbiobe on Indexed.vc" width="260" height="76" /></a>